General MedicationsTOPICALStandard
MITOSOL
MITOMYCIN
Standard Dose
0.2MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview MITOSOL is listed in Drugs@FDA under application 022572 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient MITOMYCIN Form and strength FOR SOLUTION;TOPICAL - 0.2MG/VIAL Sponsor GLAUKOS Submission history Latest submission status date: 2021-04-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview MITOSOL is listed in Drugs@FDA under application 022572 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MITOMYCIN Form and strength FOR SOLUTION;TOPICAL - 0.2MG/VIAL Sponsor GLAUKOS Submission history Latest submission status date: 2021-04-23 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.